
Fresenius Medical Care Overhauls China Strategy to Focus on Innovation
Fresenius Medical Care is narrowing its commercial footprint in China, exiting the local peritoneal dialysis market and discontinuing its 4008A hemodialysis system. The company aims to prioritize high-end, locally relevant medical technologies to capture growth in a region that accounts for roughly 7% of its Care Enablement segment revenue.
























